"Amy" is a real patient. Her name has been changed for confidentiality.
Amy
-
Amy is a 53-year-old woman diagnosed with Type I hereditary angioedema (HAE).
-
She had her first attack at age 12, but was not diagnosed until age 39.
-
In her late 30s, Amy experienced laryngeal attacks treated with epinephrine and continued to have laryngeal and abdominal swelling.
-
Amy’s protracted history of HAE demonstrates the multiple factors that contribute to disease burden and can diminish QoL (1).
-
Several years ago, she elected to undergo long-term prophylaxis.
-
Amy has been able to prevent attacks and assessments show that she now enjoys a considerably improved QoL.
Family History
-
Amy’s father and 2 sons have Type I HAE.
Comorbidities
-
Rheumatoid arthritis
-
Stage II hypertension
-
Hypothyroidism
-
Obesity
Current Medications
-
Methotrexate 10 mg per week
-
Levothyroxine 50 mcg QD
-
Azilsartan medoxomil 80 mg QD
-
Calcium supplement
-
Long-term prophylaxis with subcutaneous
kallikrein inhibitor